Janney Montgomery Scott
RNAM

Janney Montgomery Scott’s Avidity Biosciences RNAM Stock Holding History

Janney Montgomery Scott’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,970
Closed -$478K – 3004
2025
Q3 		$478K Buy
+10,970
New +$443K ﹤0.01% 2174
2025
Q1 		– Sell
-8,700
Closed -$253K – 2839
2024
Q4 		$253K Buy
8,700
+240
+3% +$10K ﹤0.01% 2417
2024
Q3 		$389K Sell
8,460
-1,090
-11% -$47.3K ﹤0.01% 2132
2024
Q2 		$390K Buy
9,550
+900
+10% +$25.8K ﹤0.01% 2066
2024
Q1 		$221K Buy
+8,650
New +$136K ﹤0.01% 2516
2023
Q3 		– Sell
-11,484
Closed -$127K – 2738
2023
Q2 		$127K Buy
11,484
+34
+0.3% +$426 ﹤0.01% 2535
2023
Q1 		$176K Buy
+11,450
New +$252K ﹤0.01% 2311

Other funds holding RNAM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Janney Montgomery Scott's RNAM Position: Q4 2025 in Review

Janney Montgomery Scott sold out of Avidity Biosciences (RNAM) in Q4 2025, closing a stake of 10,970 shares — an estimated $478K sold.

Janney Montgomery Scott first reported a position in RNAM in Q1 2023 and held it in 7 quarters. The position peaked at $478K in Q3 2025. 343 funds tracked by Wall St. Rank hold RNAM as of Q4 2025.

  • Janney Montgomery Scott reported no remaining Avidity Biosciences position as of Q4 2025 after selling out during the quarter.
  • Janney Montgomery Scott sold 10,970 Avidity Biosciences shares in Q4 2025, an estimated $478K.
  • Janney Montgomery Scott first reported a position in Avidity Biosciences in Q1 2023 and held it in 7 quarters.
  • Janney Montgomery Scott's Avidity Biosciences position peaked at $478K in Q3 2025.
  • 343 funds tracked by Wall St. Rank held Avidity Biosciences as of Q4 2025.

Based on Janney Montgomery Scott's 13F filing for Q4 2025, filed 11 Feb 2026.